CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,084 enrolled
Drug / intervention
No interventiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00791518
NCT00791518N/ACompleted

An Evaluation of Lung Function and Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

GlaxoSmithKline·observational·Posted Nov 14, 2008·Updated Jul 30, 2014

In Brief

An observational study evaluating No intervention for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 1,084 participants across 57 sites.

Detailed Summary

A multicenter study to evaluate lung function and symptoms in subjects with COPD who have been on regular use of only one long-acting bronchodilator.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 14, 2008
Enrollment StartDec 1, 2008
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.6 years ago

Interventions

No interventiondrug

No intervention